Related Experiment Video
Updated: Jul 20, 2025
08:10
Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
1.7K
Research progress of non-coding RNA in atrial fibrillation
Zongqian Xue1, Jinbiao Zhu1, Juan Liu1
1Department of Cardiology, Aoyang Hospital Affiliated to Jiangsu University, Zhangjiagang, China.
Frontiers in Cardiovascular Medicine
|July 31, 2023
Summary
Atrial fibrillation (AF) is a growing health concern, especially with an aging population. Research into non-coding RNAs (ncRNAs) may offer new diagnostic markers and targeted therapies for this common heart rhythm disorder.
Area of Science:
- Cardiology
- Molecular Biology
- Genetics
Background:
- Atrial fibrillation (AF) is a prevalent cardiac arrhythmia with increasing incidence, particularly in aging populations.
- AF significantly impacts patient quality of life and can lead to severe complications like thrombosis and heart failure.
- Current diagnostic and therapeutic strategies for AF lack specific serum markers and targeted treatments.
Purpose of the Study:
- To explore the role of non-coding RNAs (ncRNAs) in the pathophysiology of atrial fibrillation.
- To identify potential ncRNA biomarkers for AF diagnosis.
- To investigate ncRNAs as targets for novel AF therapies.
Main Methods:
- Review of current literature on ncRNAs in cardiovascular diseases.
- Analysis of studies investigating ncRNA involvement in AF development and progression.
- Exploration of ncRNAs in other cardiovascular conditions like myocardial infarction and atherosclerosis.
Main Results:
- ncRNAs are implicated in the occurrence and development of AF.
- ncRNAs play roles in the pathophysiological processes of myocardial infarction and atherosclerosis.
- ncRNAs show potential as biomarkers for cardiovascular diseases, including AF.
Conclusions:
- Understanding the pathophysiological mechanisms of AF involving ncRNAs is crucial.
- ncRNAs represent promising targets for the development of specific diagnostic markers and targeted therapies for AF.
- Further research into ncRNAs can lead to a more systematic diagnostic and treatment framework for atrial fibrillation.
Related Concept Videos
02:39lncRNA - Long Non-coding RNAs
8.6K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
02:23RNA Editing
9.0K
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
9.0K